Sunil Vandse

Sunil is Vice President, Research & Development at Vertice Pharma. He has more than 25 years of varied experience in leading development of generics as well as innovative products for several generic and specialty pharmaceutical companies. Most recently he was Executive Director, Product Development at Vertice. Prior to Vertice, he was Executive Director, Research and Development at Endo Pharmaceuticals / Par Pharmaceuticals, responsible for product development of complex generics including solid orals, injectables, nasal sprays and topical dosage forms. Prior to Endo, Sunil held various roles of increasing responsibilities at Sandoz. He also worked in various positions in R&D of Actavis, Lupin Laboratories, Torrent pharmaceuticals and Cadila Laboratories. Throughout his career, his leadership has resulted in submission of more than 100 ANDAs including first to file and first to market opportunities. Sunil holds a Master of Pharmacy (M.Pharm) from the Birla Institute of Technology in India and a Bachelor of Pharmacy from Government College of Pharmacy, Bangalore in India. He also holds several patents.